Combined Synopsis/Solicitation for InterOperability Bidco Rhapsody Software Subscription
ID: 75D30125Q78592Type: Combined Synopsis/Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Software Publishers (513210)

PSC

IT AND TELECOM - BUSINESS APPLICATION SOFTWARE (PERPETUAL LICENSE SOFTWARE) (7A21)

Original Source

https://sam.gov/opp/deae47d92d764328b7a8d97588e4689e/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting quotes for a sole source contract for an annual software subscription and maintenance support for Rhapsody software from InterOperability Bidco. This procurement is critical for enhancing data interoperability within the CDC’s Enterprise Laboratory Information Management System (ELIMS) project, which aims to standardize electronic laboratory result messaging for secure data transfer among public health agencies. The contract, valued at approximately $118,226.37, will span from February 1, 2025, to January 31, 2030, with options for four additional years, and emphasizes the necessity of ongoing software updates, technical support, and compliance with healthcare standards. Interested parties can reach out to James Brown III at xvn8@cdc.gov or Eric Lyons at kpy2@cdc.gov for further information.

    Point(s) of Contact
    James Brown III
    xvn8@cdc.gov
    Eric Lyons
    kpy2@cdc.gov
    Files
    Title
    Posted
    Combined Synopsis Solicitation_75D30125Q78592.pdf
    The Centers for Disease Control and Prevention (CDC) is soliciting quotes for a sole source contract for an annual software subscription and maintenance support for Rhapsody software from InterOperability Bidco. This procurement is essential for enhancing data interoperability within the CDC’s Enterprise Laboratory Information Management System (ELIMS) project, which standardizes electronic laboratory result messaging to facilitate secure data transfer among public health agencies. The contract spans from February 1, 2025, to January 31, 2030, with options for four additional years, and underscores the importance of maintaining software updates, technical support, and compliance with healthcare standards. The vendor will ensure ongoing maintenance services, including security fixes and software upgrades, to support the secure, reliable operation of the CDC's ELIMS system. Detailed requirements regarding documentation, training, compliance with federal security standards, and release notes for upgrades are included to ensure operational continuity and effectiveness of public health data exchange efforts. This procurement aligns with federal acquisition guidelines and emphasizes the critical role of robust software support in managing public health data efficiently.
    Source Source Justification.pdf
    The document outlines a justification for a sole source procurement by the Centers for Disease Control and Prevention (CDC) to acquire ongoing software maintenance and support for Rhapsody software from InterOperability Bidco, the original developer and exclusive provider. The estimated procurement amount is $118,226.37. The justification emphasizes that only one source is available due to the proprietary nature and exclusive licensing agreements surrounding the Rhapsody software, which is integral to the CDC's Infectious Diseases Enterprise Laboratories. Key reasons for this sole source acquisition include the software's unique capabilities in securing real-time public health data exchanges, its proven compatibility with CDC systems, and the significant investment already made in Rhapsody-based workflows. Alternative products, such as Mirth Connect and Cloverleaf, were evaluated but deemed inadequate due to a lack of critical features, required complexity, and insufficient support for healthcare data standards. Maintaining Rhapsody is crucial for operational continuity while transitioning to the CDC's future solution, ReportStream. The document concludes with certifications from the Program Official and the Contracting Officer affirming the necessity of this procurement under federal acquisition regulations.
    Lifecycle
    Title
    Type
    Combined Synopsis/Solicitation for InterOperability Bidco Rhapsody Software Subscription
    Currently viewing
    Combined Synopsis/Solicitation
    Similar Opportunities
    Notice of Intent to Sole Source - QuidelOrtho Corporation
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to QuidelOrtho Corporation for a service agreement related to the VITROS 3600 Immunodiagnostic system. This procurement includes essential services such as the provision of reagents, calibrators, controls, and consumables, as well as repairs, labor, and travel incurred during service calls, along with one annual preventive maintenance and on-site technical support. The VITROS 3600 system plays a critical role in the laboratory's operations within the Division of Viral Hepatitis, ensuring accurate diagnostic capabilities. Interested vendors with relevant expertise are encouraged to submit their capabilities and pricing information to Leyla Campbell at LCampbell@cdc.gov by February 6, 2025, at 11:00 AM ET, as the government will consider all submissions to determine if competitive procurement is warranted.
    CDC DFWED NARST Sensititre Supplies
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    RENEWAL OF SOFTWARE LICENSE, MAINTENANCE AND SUPPORT FOR GENEDATA ANALYST (AMBIS 2253271)
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), intends to negotiate a sole-source contract for the renewal of the Genedata Analyst software license, along with maintenance and support services. This procurement is essential for the ongoing bioinformatics and statistical analysis of large ‘multi-omics’ datasets, which are critical for understanding immune responses in human samples during influenza A virus vaccination and infection studies. The software plays a vital role in the research conducted by the Viral Pathogenesis and Evolution Section, aiding in the development of novel vaccines and antiviral therapies. Interested vendors must submit capability statements via the NIH electronic Simplified Acquisition Submission System (eSASS) by 4:00 PM EST on January 31, 2025, and can contact Rita Davis at rita.davis@nih.gov or Tonia Alexander at talexander@niaid.nih.gov for further information.
    PRIMO Software Licensing
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    Pre-Solicitation FY 2025 CDC OS Emerging Public Health Priorities BAA
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is preparing to issue a Fiscal Year 2025 Broad Agency Announcement (BAA) for Applied Research aimed at addressing Emerging Public Health Priorities. This initiative seeks innovative research proposals in various areas, including infectious disease surveillance, wastewater surveillance, and substance use disorder recovery, to enhance public health strategies and responses to emerging threats. The BAA will be open for full and open competition, with a tentative issuance date of December 30, 2024, and a due date for concept papers set for January 30, 2025. Interested contractors must ensure they are registered in the System for Award Management (SAM) to be eligible for award, and further details will be available on SAM.gov.
    Notice of Intent to Sole Source – TheraDoc subscription
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) Clinical Center intends to award a firm fixed-price purchase order for subscription services related to the TheraDoc application, exclusively owned by Premier Healthcare LLC. This procurement aims to secure applications, support, maintenance, and training for the TheraDoc clinical surveillance solution, which is critical for enhancing healthcare delivery and patient safety. The acquisition will follow the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, allowing for a sole-source solicitation due to the unique nature of the services required. Interested parties may express their capabilities and submit comments to the NIH by November 21, 2024, with inquiries directed to Ryssa Nix at Ryssa.nix@nih.gov.
    Serological Assays for the Detection and Characterization of Influenza Viruses
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is soliciting proposals for a contract focused on serological assays for the detection and characterization of influenza viruses. The primary objectives include performing hemagglutination inhibition assays on human serum samples and developing new serology platforms that are comparable to existing methods. This initiative is crucial for enhancing influenza surveillance and vaccine effectiveness studies, addressing ongoing public health challenges. Interested parties must submit a Letter of Interest by 2:00 PM EST on February 7, 2025, and can contact Jennifer Gartzke at jgartzke@cdc.gov or 404-498-0020 for further information.
    Lateral Flow Assay (LFA) validation and manufacturing
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking qualified sources for the validation and manufacturing of lateral flow assays (LFA) aimed at diagnosing HIV antiretroviral usage in point-of-care settings. The CDC requires an established medical device company capable of producing 25,000 lateral flow devices, which will be utilized in pre-clinical and clinical studies, with the contractor responsible for adapting the provided technical design to their production pipeline and optimizing test performance. This initiative is part of the broader effort to enhance HIV prevention and treatment strategies, emphasizing the need for rapid and cost-effective assays to monitor drug levels. Interested parties must submit their responses, including organizational details and relevant project experience, to Mark Wirtz at mag8@cdc.gov by January 31, 2025, at 12:00 p.m. EST, as this notice is for market research purposes only and does not constitute a solicitation for proposals.
    Request for Information - Centers for Disease Control and Prevention / National Institute of Occupational Safety and Health / World Trade Center Health Program
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is issuing a Request for Information (RFI) to gather industry feedback on a draft Performance Work Statement (PWS) related to the operation of a Survivor Clinical Center of Excellence (CCE) for individuals affected by the September 11, 2011 terrorist attacks in the New York metropolitan area. The objective of this procurement is to ensure continued health monitoring and treatment for eligible survivors, with the CDC seeking input on the clarity, completeness, and feasibility of the draft PWS to enhance the potential procurement process. This initiative is critical for providing necessary healthcare services to a vulnerable population, and the feedback received will help refine the evaluation techniques for selecting qualified vendors. Interested parties must submit their feedback to Serina Allingham at xog9@cdc.gov by 12:00 EST on January 31, 2025, and should note that this RFI is for information purposes only and does not constitute a solicitation for proposals.
    CDC WORLD TRADE CENTER (WTC) HEALTH PROGRAM PHARMACY BENEFITS MANAGER
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking qualified vendors to provide Pharmacy Benefits Manager (PBM) services for the World Trade Center (WTC) Health Program, which supports responders and survivors affected by the 9/11 attacks. The procurement aims to operationalize a three-year contract that includes a 12-month implementation period, a peak operational phase, and a transition-out period, all while ensuring compliance with federal regulations and managing pharmacy benefits for a limited healthcare program. The PBM will be responsible for developing a pharmacy network, implementing electronic claims processing systems, conducting audits, and maintaining transparent pricing, among other tasks, to ensure optimal care for enrollees. Interested parties must submit their qualifications by February 14, 2025, and can direct inquiries to Laurie Presley at xnp0@cdc.gov.